Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 39 | 38 | −1 |
| Shares | 6.46M | 4.03M | −2.42M (−37.5%) |
| Value | $3.32M | $2.02M | −$1.30M (−39.3%) |
New holders (6)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 113,206 | $56.0K | 0.00% |
| XTX Topco Ltd | 44,077 | $22.0K | 0.00% |
| Renaissance Technologies LLC | 24,908 | $12.4K | 0.00% |
| ACT Advisors, LLC. | 14,806 | $7.40K | 0.00% |
| EverSource Wealth Advisors, LLC | 980 | $490 | 0.00% |
| Simplex Trading, LLC | 819 | $0 | 0.00% |
Sold out (7)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Armistice Capital, LLC | 3,151,354 | $1.62M |
| Bridgeway Capital Management, LLC | 46,500 | $23.9K |
| Gsa Capital Partners LLP | 25,391 | $13.0K |
| JustInvest LLC | 15,396 | $7.91K |
| Raymond James Financial Inc | 2,954 | $1.52K |
| The PNC Financial Services Group, Inc. | 2,000 | $1.03K |
| Ameritas Advisory Services, LLC | 280 | $144 |